- ►diabetesjournals.org G Targher, L Bertolini, F Poli, S Rodella, L … - Diabetes, 2005 - Am Diabetes Assoc Nonalcoholic fatty liver disease (NAFLD) is closely correlated to several
metabolic syndrome features. We assessed prospectively whether NAFLD predicts
future cardiovascular disease (CVD) events among type 2 diabetic ... Cited by 114 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] S Tamura, I Shimomura - Journal of Clinical Investigation, 2005 - Am Soc Clin Investig Nonalcoholic fatty liver disease (NAFLD) is a component of the metabolic
syndrome, with a clinical spectrum ranging from simple fatty liver to
steatohepatitis, cirrhosis, and hepatocellular carcinoma. The primary event ... Cited by 47 - Related articles - All 11 versions
A Lonardo, C Carani, N Carulli, P Loria - Journal of hepatology, 2006 - Elsevier In 1980, Ludwig named nonalcoholic steatohepatitis (NASH) what we now consider
to be one of the manifestations of the broader nonalcoholic fatty liver disease
(NAFLD) spectrum. He described 20 patients whose liver biopsy specimens ... Cited by 28 - Related articles - All 11 versions
SH Caldwell, CK Argo, A Al-Osaimi - Journal of Clinical Gastroenterology, 2006 - journals.lww.com Abstract: Insulin resistance is an integral part of the underlying
pathophysiology in most patients with nonalcoholic fatty liver disease (NAFLD).
Insulin-sensitiziting agents are therefore likely to be of key importance ... Cited by 28 - Related articles - BL Direct - All 3 versions
N Méndez-Sánchez, AR Villa, NC Chávez- … - Ann Hepatol, 2005 - medigraphic.com Page 1. Otras secciones de este sitio: ... Cited by 26 - Related articles - All 5 versions
- Free from Publisher KG Tolman, V Fonseca, A Dalpiaz, MH Tan - Diabetes Care, 2007 - Am Diabetes Assoc Diabetes, by most estimates, is now the most common cause of liver disease in
the US Cryptogenic cirrhosis, of which diabetes is, by far, the most common
cause, has become the third leading indication for liver transplantation in ... Cited by 21 - Related articles - All 6 versions
SK Lazerow, MS Abdi, JH Lewis - Current opinion in gastroenterology, 2005 - journals.lww.com Purpose of review To summarize the salient reviews, studies and case reports and
series that dealt with clinical, pathological, methodological, and
epidemiological descriptions of drug-induced liver disease in the calendar ... Cited by 20 - Related articles - All 5 versions
G Marchesini, G Forlani, E Bugianesi - Annals of Medicine, 2005 - informahealthcare.com The association of metabolic disorders with liver disease is receiving
increasing attention in the gastroenterological community. Cohort studies have
shown that advanced liver disease may stem from metabolic disorders, via ... Cited by 20 - Related articles - BL Direct - All 7 versions
- ►endojournals.org N Matikainen, S Manttari, J Westerbacka, S … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Results: Subjects with high liver fat displayed increased response of
postprandial lipids in plasma, chylomicron, and very-low-density lipoprotein 1
(VLDL1) (Svedberg flotation rate 60–400) fractions. Liver fat correlated ... Cited by 16 - Related articles - BL Direct - All 4 versions
R Palacios, N Merchante, J Macías, M … - Antiviral Therapy, 2006 - intmedpress.com Objectives: to assess the incidence and risk factors for insulin resistance (IR)
in a cohort of naive HIV-infected patients 48 weeks after starting highly active
antiretro- viral therapy (HAART). Design: prospective, two centre, ... Cited by 13 - Related articles - BL Direct - All 4 versions
